Ledger.Open graph →
SEC Form D · filed April 14, 2023

CHARM Therapeutics Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Other
Location
London, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Nihal S. Sinha · London, United KingdomDirectorLakshyaditya S. Aithani · London, United KingdomExec · DirectorRishi S. Gupta · London, United KingdomDirectorGary S. Glick · London, United KingdomDirectorMuzammil S. Mansuri · London, United KingdomDirectorWilliam Weatherford · Tampa, FLExec · DirectorYousif Al-Dujaili · Brooklyn Heights, NYDirectorJohn Penrose · Boston, MADirectorMichael R. Aceti · Dover, MADirectorAndrew Weatherford · Tampa, FLDirectorThomas Kaiman · Chesterfield, MODirectorJames A. Cook, Jr · Wentzville, MODirectorIan Malloch · Stamford, CTDirectorWarren Keens · West Bay, Cayman IslandsExec · DirectorYedid Capital Management, LLC · Miami Beach, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗